Company intelligence / Profile preview

Marbles Health

Ownership: Private
Development stage: Commercial

Overview

EASE, Marbles Health’s flagship portable, non-invasive brain stimulation device for depression, demonstrated a 63.8% reduction in depression symptoms within 10 days during clinical trials. The device has received CDSCO approval and integrates tES, EEG, and cognitive-emotional training for rapid mental health improvement[1][3][4].

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Department of Biotechnology, Government of India [2][3]AIIMS New Delhi [2][3]

Beyond the preview

Go deeper on Marbles Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marbles Health.

Explore the full profile